The Online Investor
OLI Premium
Contrarian Outlook
Stock Option Ideas
Preferred Stock Newsletter
ChartZero.com
ChartZero
Molecular Templates Inc (MTEM)

Molecular Templates is a clinical-stage company focused on the discovery and development of biologic therapeutic for cancer and other serious diseases. Co. utilizes its proprietary biologic drug platform to design and generate engineered toxin bodies (ETBs). Co. is developing ETBs for various targets, including CD20, CD38, HER2, PD-L1, CTLA-4, SLAMF-7, and CD45. CD20 is central to B cell malignancies and is clinically validated as a target for the treatment of lymphomas and autoimmune disease. CD38 has been validated as a clinical target in the treatment of various myeloma. PD-L1 is central to immune checkpoint pathways and is a target expressed in a variety of solid tumor cancers.

MTEM SEC Filing Email Alerts Service

Company Name:  Molecular Templates Inc
Website:  www.mtem.com
Sector:  Drugs & Pharmaceuticals
Number of ETFs Holding MTEM:  18
Total Market Value Held by ETFs:  $32.00M
Total Market Capitalization:  $545.00M
% of Market Cap. Held by ETFs:  5.87%
March 3, 2021    5:55 AM Eastern


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Quotes delayed 20 minutes



Strong Buy (3.71 out of 4)
70th percentile
(ranked higher than approx. 70% of all stocks covered)

Analysts' Target Price:
MTEM Stock Forecast

Based on Zacks ABR data;
powered by Xignite

Molecular Templates Inc (MTEM) Page | The Online Investor | www.TheOnlineInvestor.com | Copyright © 1998 - 2021, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.